Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Operating Leases: 2019-2024

Historic Operating Leases for Bicycle Therapeutics (BCYC) over the last 6 years, with Dec 2024 value amounting to $4.0 million.

  • Bicycle Therapeutics' Operating Leases fell 82.27% to $981,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $981,000, marking a year-over-year decrease of 82.27%. This contributed to the annual value of $4.0 million for FY2024, which is 57.47% down from last year.
  • Bicycle Therapeutics' Operating Leases amounted to $4.0 million in FY2024, which was down 57.47% from $9.4 million recorded in FY2023.
  • Over the past 5 years, Bicycle Therapeutics' Operating Leases peaked at $12.1 million during FY2021, and registered a low of $426,000 during FY2020.
  • In the last 3 years, Bicycle Therapeutics' Operating Leases had a median value of $9.4 million in 2023 and averaged $8.1 million.
  • Its Operating Leases has fluctuated over the past 5 years, first slumped by 65.95% in 2020, then soared by 2,735.92% in 2021.
  • Bicycle Therapeutics' Operating Leases (Yearly) stood at $426,000 in 2020, then soared by 2,735.92% to $12.1 million in 2021, then fell by 9.90% to $10.9 million in 2022, then fell by 13.81% to $9.4 million in 2023, then crashed by 57.47% to $4.0 million in 2024.